Study led by City of Hope, TGen shows new way of ID'ing tumor response to immunotherapy

(City of Hope) Scientists at City of Hope, working in collaboration with researchers at Translational Genomics Research Institute (TGen), have found that the actions of circulating immune cells -- namely how they differentiate and signal -- at the start of immunotherapy treatment for cancer can inform how a patient will respond to the therapy. The team's findings will publish this week in the Proceedings of the National Academy of Sciences of the United States of America.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news